Arena S - Search Results

1

Efficacy of Retreatment with Oxaliplatin-Based Regimens in Metastatic Colorectal Cancer Patients: The RETROX-CRC Retrospective Study.

Amatu A, Mauri G, Tosi F, Bencardino K, Bonazzina E, Gori V, Ruggieri L, Arena S, Bardelli A, Marsoni S, Siena S, Sartore-Bianchi A. Amatu A, et al. Among authors: arena s. Cancers (Basel). 2022 Feb 25;14(5):1197. doi: 10.3390/cancers14051197. Cancers (Basel). 2022. PMID: 35267504 Free PMC article.

2

Identification of cancer genes by mutational profiling of tumor genomes.

Benvenuti S, Arena S, Bardelli A. Benvenuti S, et al. Among authors: arena s. FEBS Lett. 2005 Mar 21;579(8):1884-90. doi: 10.1016/j.febslet.2005.02.015. FEBS Lett. 2005. PMID: 15763568 Free article. Review.

3

Genetic analysis of the kinome and phosphatome in cancer.

Arena S, Benvenuti S, Bardelli A. Arena S, et al. Cell Mol Life Sci. 2005 Sep;62(18):2092-9. doi: 10.1007/s00018-005-5205-1. Cell Mol Life Sci. 2005. PMID: 16132230 Review.

4

Genetic targeting of the kinase activity of the Met receptor in cancer cells.

Arena S, Pisacane A, Mazzone M, Comoglio PM, Bardelli A. Arena S, et al. Proc Natl Acad Sci U S A. 2007 Jul 3;104(27):11412-7. doi: 10.1073/pnas.0703205104. Epub 2007 Jun 26. Proc Natl Acad Sci U S A. 2007. PMID: 17595299 Free PMC article.

5

Knock-in of oncogenic Kras does not transform mouse somatic cells but triggers a transcriptional response that classifies human cancers.

Arena S, Isella C, Martini M, de Marco A, Medico E, Bardelli A. Arena S, et al. Cancer Res. 2007 Sep 15;67(18):8468-76. doi: 10.1158/0008-5472.CAN-07-1126. Cancer Res. 2007. PMID: 17875685

6

PIK3CA cancer mutations display gender and tissue specificity patterns.

Benvenuti S, Frattini M, Arena S, Zanon C, Cappelletti V, Coradini D, Daidone MG, Pilotti S, Pierotti MA, Bardelli A. Benvenuti S, et al. Among authors: arena s. Hum Mutat. 2008 Feb;29(2):284-8. doi: 10.1002/humu.20648. Hum Mutat. 2008. PMID: 18022911

7

Understanding how kinase-targeted therapies work.

Arena S, Bardelli A. Arena S, et al. Cell Cycle. 2008 Jun 1;7(11):1560-3. doi: 10.4161/cc.7.11.6031. Epub 2008 Mar 30. Cell Cycle. 2008. PMID: 18469513

8

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.

Di Nicolantonio F, Martini M, Molinari F, Sartore-Bianchi A, Arena S, Saletti P, De Dosso S, Mazzucchelli L, Frattini M, Siena S, Bardelli A. Di Nicolantonio F, et al. Among authors: arena s. J Clin Oncol. 2008 Dec 10;26(35):5705-12. doi: 10.1200/JCO.2008.18.0786. Epub 2008 Nov 10. J Clin Oncol. 2008. PMID: 19001320 Free article.

9

Expression and functional regulation of myoglobin in epithelial cancers.

Flonta SE, Arena S, Pisacane A, Michieli P, Bardelli A. Flonta SE, et al. Among authors: arena s. Am J Pathol. 2009 Jul;175(1):201-6. doi: 10.2353/ajpath.2009.081124. Epub 2009 Jun 18. Am J Pathol. 2009. PMID: 19541931 Free PMC article.

10

Integrated molecular dissection of the epidermal growth factor receptor (EGFR) [corrected] oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer.

Sartore-Bianchi A, Bencardino K, Di Nicolantonio F, Pozzi F, Funaioli C, Gambi V, Arena S, Martini M, Lamba S, Cassingena A, Schiavo R, Bardelli A, Siena S. Sartore-Bianchi A, et al. Among authors: arena s. Target Oncol. 2010 Mar;5(1):19-28. doi: 10.1007/s11523-010-0138-5. Epub 2010 Apr 11. Target Oncol. 2010. PMID: 20383783 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

428 results

Search Page